Advertisement
UK markets closed
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • HANG SENG

    16,541.42
    +148.58 (+0.91%)
     
  • CRUDE OIL

    83.11
    +1.76 (+2.16%)
     
  • GOLD FUTURES

    2,240.40
    +27.70 (+1.25%)
     
  • DOW

    39,756.78
    -3.30 (-0.01%)
     
  • Bitcoin GBP

    56,084.48
    +1,653.27 (+3.04%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • NASDAQ Composite

    16,368.48
    -31.04 (-0.19%)
     
  • UK FTSE All Share

    4,338.05
    +12.12 (+0.28%)
     

Better Buy: Eli Lilly vs. Johnson & Johnson

Better Buy: Eli Lilly vs. Johnson & Johnson

As two of the largest healthcare companies in the world, both Eli Lilly (NYSE: LLY) and Johnson & Johnson (NYSE: JNJ) have a role to play in well-balanced healthcare portfolios. With a profit margin of 23.8%, 15.1% year-over-year quarterly revenue growth, and trailing-12-month revenues of $23.1 billion, Eli Lilly exudes success.